My Top Biotech Stocks to Buy in the Market Crash
The worst may be yet to come for the stock market, but these biopharma companies have promising potential.
Here's Why Deciphera Pharmaceuticals Lost 22.7% in March
Investors are concerned that an important regulatory deadline for the development-stage drug developer will be delayed because of the coronavirus pandemic.
Here's Why Epizyme Lost 27.6% in March
Investors were looking forward to the drug company's transition to commercial operations, but the coronavirus pandemic could delay the maturation process.
Here's Why Albemarle Stock Fell 31.1% in March
The world's largest lithium producer was bracing for a difficult 2020. Then the coronavirus pandemic hit.
Here's Why Invitae Tumbled 32.9% in March
Growth stocks were among the most severely punished during the recent stock market crash.
Here's Why Bloom Energy Fell 42.3% in March
The stock's compounding momentum proved no match for the coronavirus pandemic.
Here's Why Fate Therapeutics Rose as Much as 18.7% Today
The cellular therapy developer announced an equity investment from and a partnership with Janssen, a subsidiary of Johnson & Johnson.
Gold Stocks Soared Thursday as Investors Digested Sour Economic Data
Precious metals are thriving on the current economic upheaval.
Alliance Resource Partners Soared Today After Touching 20-Year Lows
Despite today's bounce, the coal producer faces an uncertain path ahead.
Here's Why Invitae Stock Is Swinging Wildly Today
The company announced the pricing of a public offering of common stock.
U.S. Coal-Fired Power Plants Stumbled Into 2020
Electricity generation from coal fell 35% in January 2020 from the year-ago period.
So Your Biotech Announced Positive Phase 3 Results? Celebrating Could be Premature
Success in clinical trials doesn't guarantee success on the market.
Here's Why Alliance Resource Partners Stock Fell as Much as 13.9% Today
The company announced actions in response to the global economic slowdown caused by the coronavirus.
Here's Why Axsome Therapeutics Fell as Much as 14.7% Today
An important clinical trial delivered mixed results.
Will a Strong Balance Sheet Protect Renewable Energy Group?
Selling prices for crude oil and biomass-based diesel are crashing at the worst possible time for the business.
Beyond Meat Stock Pops on Stimulus Hopes, but Is It Premature?
Investors are anticipating a massive stimulus deal -- but it's only meant to soften the economic blow, not avoid it altogether.
Lithium Demand for Electric Vehicles Could Grow 599% by 2025
The projections are likely to take a hit from the coronavirus pandemic, but the future for lithium remains strong.
Here's Why The Best Is Yet to Come for Axsome Therapeutics
There are tangible near-term risks to the business in the face of the coronavirus pandemic, but investors with a long-term mindset could find this pharma stock attractive.
Here's Why Gold and Silver Stocks Jumped Today
The market's wild ride through March continued, lifting prices of gold and silver from recent lows.
Alliance Resource Partners Stock Keeps Falling
The dividend stock is no stranger to volatility, but this time might be different.